↓ Skip to main content

American Association for Cancer Research

Article Metrics

U.S. FDA Drug Approvals for Breast Cancer — A Decade in Review

Overview of attention for article published in Clinical Cancer Research, October 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

twitter
214 tweeters

Readers on

mendeley
10 Mendeley
Title
U.S. FDA Drug Approvals for Breast Cancer — A Decade in Review
Published in
Clinical Cancer Research, October 2021
DOI 10.1158/1078-0432.ccr-21-2600
Pubmed ID
Authors

Shaily Arora, Preeti Narayan, Christy L. Osgood, Suparna Wedam, Tatiana M. Prowell, Jennifer J. Gao, Mirat Shah, Danielle Krol, Sakar Wahby, Melanie Royce, Soma Ghosh, Reena Philip, Gwynn Ison, Tara Berman, Christina Brus, Erik W. Bloomquist, Mallorie H. Fiero, Shenghui Tang, Richard Pazdur, Amna Ibrahim, Laleh Amiri-Kordestani, Julia A. Beaver

Twitter Demographics

The data shown below were collected from the profiles of 214 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 30%
Professor > Associate Professor 1 10%
Researcher 1 10%
Unknown 5 50%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 20%
Medicine and Dentistry 2 20%
Agricultural and Biological Sciences 1 10%
Unknown 5 50%

Attention Score in Context

This research output has an Altmetric Attention Score of 146. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2022.
All research outputs
#188,748
of 19,985,377 outputs
Outputs from Clinical Cancer Research
#72
of 11,788 outputs
Outputs of similar age
#6,520
of 416,577 outputs
Outputs of similar age from Clinical Cancer Research
#5
of 176 outputs
Altmetric has tracked 19,985,377 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,788 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 416,577 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 176 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.